| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | RADIUS HEALTH | 5,831,253 | 404,164,000 | 62.17% | ||
| 2 | CHIASMA INC | 5,681,544 | 112,949,000 | 17.38% | ||
| 3 | PORTOLA PHARMACEUTICALS INC | 1,220,672 | 52,025,000 | 8.00% | ||
| 4 | EPIZYME INC COM | 1,729,674 | 22,244,000 | 3.42% | ||
| 5 | Proteon Therapeutics | 983,381 | 13,679,000 | 2.10% | ||
| 6 | NEVRO CORP | 211,884 | 9,829,000 | 1.51% | ||
| 7 | ARATANA THERAPEUTICS INC COM | 1,117,875 | 9,457,000 | 1.45% | ||
| 8 | TRIVASCULAR TECHNOLOGIES INC | 1,776,692 | 8,883,000 | 1.37% | ||
| 9 | PHARMATHENE INC COM | 6,347,614 | 8,442,000 | 1.30% | ||
| 10 | CONATUS PHARMACEUTICALS INC COM | 1,192,080 | 5,305,000 | 0.82% | ||
| 11 | MAST THERAPEUTICS | 2,551,851 | 1,480,000 | 0.23% | ||
| 12 | VERASTEM INC COM | 572,874 | 1,025,000 | 0.16% | ||
| 13 | ENTEROMEDICS INC | 1,113,168 | 289,000 | 0.04% | ||
| 14 | SANGAMO BIOSCIENCES INCORPORATED | 22,487 | 127,000 | 0.02% | ||
| 15 | COLUCID PHARMACEUTICALS INC COM | 21,806 | 84,000 | 0.01% | ||
| 16 | MACROGENICS INC | 3,168 | 68,000 | 0.01% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0000950123-15-011440, filed 2015.11.12).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
